US FDA approves first test to detect risk of addiction to opioids
The US Food and Drug Administration said it has approved the first test to assess whether certain people are at risk of addiction to opioids. The AvertD test was developed by SOLVD Health, a private company. The FDA approved AutoGenomics, a division that SOLVD acquired in 2019.
POPULAR POSTS
Heavy rains in Bolivia cause rivers to overflow their banks
November 26, 2024
Divisions over plastic waste reduction persist
November 26, 2024
Swedish crime drama ‘Veronika’ renewed for a second season
November 26, 2024
LIVE STREAM